利用海洋的药房:海洋生物活性化合物作为下一代治疗药物
1Center for Global Health Research, Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, Tamil Nadu, India.
Natural product research
|July 2, 2024
概括
海洋生物为新药提供独特的生物活性化合物,包括癌症药物和止痛药. 生物技术的进步为获得这些重要的海洋资源提供了可持续的解决方案.
科学领域:
- 海洋生物学 海洋生物学
- 药理学 药理学是指药理学的学科.
- 生物技术是生物技术.
背景情况:
- 海洋拥有多样化的有机体,产生具有治疗潜力的独特生物活性化合物.
- 海洋衍生药物已经产生了重要的临床应用,如抗癌剂和止痛药.
- 海洋天然产品为打击抗菌素耐药性和病毒感染提供了有前途的解决方案.
研究的目的:
- 突出海洋生物活性化合物的临床潜力.
- 讨论海洋生物活性物质可持续生产的挑战和进展.
- 强调海洋生物勘探和生物技术创新的重要性.
主要方法:
- 审查关于海洋制药的现有文献.
- 分析海洋化合物的成功临床应用.
- 探索可持续采购的生物技术方法.
主要成果:
- 海洋生物是用于药物发现的新型化合物的丰富来源,包括抗癌 (例如,特拉贝克丁) 和止痛药 (例如,齐科诺提德) 药物.
- 海洋生物活性物具有显著的抗微生物和抗病毒特性,对于应对全球健康威胁至关重要.
- 合成生物学和代谢工程正在实现可持续生产,克服传统的收获限制.
结论:
- 海洋生物活性化合物代表着一个巨大的,在很大程度上未开发的资源,用于开发创新的治疗方法.
- 克服可持续采购和生产方面的挑战是实现海洋生物制药的全部潜力的关键.
- 对海洋生物勘探和生物技术的持续投资对于未来的医学突破至关重要.
相关概念视频
Prodrugs
2.6K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.6K
Drug Biotransformation: Overview
2.4K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.4K
Targets for Drug Action: Overview
6.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.2K
Drug Discovery: Overview
7.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.8K
Principles of Drug Action
6.0K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
6.0K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


